| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 639976 | Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.0467178916101842 | 0.48208038 |
| NSC 644916 | ANTINEOPLASTIC-644916 | 0.0467178916101842 | 0.24235786 |
| NSC 651809 | Null | 0.0467178916101842 | 0.31247448 |
| NSC 655438 | Null | 0.0467178916101842 | 0.16835434 |
| NSC 671161 | Hexadecylphospho(N-acetyl)-L-serine (NH4 salt) | 0.0467178916101842 | 0.12844402 |
| NSC 672059 | Null | 0.0467178916101842 | 0.11586794 |
| NSC 678914 | 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride | 0.0467178916101842 | 0.33682904 |
| NSC 680715 | Benzaldehyde, 5-bromo-2-hydroxy- (9CI) | 0.0467178916101842 | 0.40238483 |
| NSC 684569 | Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- | 0.0467178916101842 | 0.34254006 |
| NSC 685126 | 4-Piperidinone, 3,5-bis[(4-fluorophenyl)methylene]-, (E,E)- | 0.0467178916101842 | 0.48363283 |